Abstract
Muc4/sialomucin complex (SMC) is a multifunctional glycoprotein complex which can repress apoptosis in transfected tumor cells. Its transmembrane subunit acts as an intramembrane ligand for the receptor tyrosine kinase ErbB2 to induce the phosphorylation of ErbB2 and, by acting synergistically with the ErbB3 ligand neuregulin, can potentiate the phosphorylation of ErbB2 and ErbB3. In the present study we show that Muc4/SMC alone robustly induces the phosphorylation of ErbB2 to enhance the tyrosine phosphate epitope (Tyr1248) recognized by anti-phospho-ErbB2. Although this tyrosine phosphorylation has been implicated in cell transformation, it does not activate any of the three mitogen-activated protein kinases (MAPKs) or protein kinase B/Akt of the phosphatidyl inositol 3-kinase pathway. Instead, Muc4/SMC expression induces up-regulation of the cell cycle inhibitor p27kip, consistent with the expression of Muc4/SMC in differentiated, rather than proliferative, epithelial cells. Interestingly, a combination of Muc4/SMC and neuregulin down-regulate p27kip and activate protein kinase B/Akt. These observations suggest that Muc4/SMC acts as a regulator of differentiation by inducing a limited phosphorylation of ErbB2 and a modulator of proliferation when acting synergistically with neuregulin to induce a more extensive phosphorylation on both ErbB2 and ErbB3.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Akiyama T, Matsuda S, Namba Y, Saito T, Toyoshima K, Yamamoto T . 1991 Mol. Cell Biol. 11: 833–842
Alroy I, Yarden Y . 1997 FEBS Lett. 410: 83–86
Arango ME, Li P, Komatsu M, Montes C, Carraway CAC, Carraway KL . 2001 Invest. Ophthalmol. Vis. Sci. 42: 2749–2756
Ballif BA, Blenis J . 2001 Cell Growth Differ. 12: 397–408
Ben-Levy R, Paterson HF, Marshall CJ, Yarden Y . 1994 EMBO J. 13: 3302–3311
Carraway III KL, Cantley LC . 1994 Cell 78: 5–8
Carraway KL, Spielman J . 1986 Mol. Cell Biochem. 72: 109–120
Carraway III KL, Sweeney C . 2001 Curr. Opin. Cell Biol. 13: 125–130
Carraway KL, Perez A, Idris N, Jepson S, Arango M, Komatsu M, Haq B, Price-Schiavi SA, Zhang J, Carraway CAC . 2002 Prog. Nucleic Acids Res. Mol. Biol. 71: 149–185
Carraway III KL, Rossi EA, Komatsu M, Price-Schiavi SA, Huang D, Carvajal ME, Guy PM, Fregien N, Carraway CAC, Carraway KL . 1999 J. Biol. Chem. 274: 5263–5266
Carraway III KL, Sliwkowski MX, Akita R, Platko JV, Guy PM, Nuijens A, Diamonti AJ, Vandlen RL, Cantley LC, Ceroine RA . 1994 J. Biol. Chem. 269: 14303–14306
DiGiovanna MP, Stern DF . 1995 Cancer Res. 55: 1946–1955
Franke TF, Kaplan DR, Cantley LC . 1997 Cell 88: 435–437
Hull SR, Sheng Z, Vanderpuye OA, David C, Carraway KL . 1990 Biochem. J. 265: 121–129
Idris N, Carraway KL . 1999 Biol. Reprod. 61: 1431–1438
Idris N, Carraway KL . 2000 J. Cell Physiol. 185: 310–316
Idris N, Carraway CAC, Carraway KL . 2001 J. Cell Physiol. 189: 162–170
Klapper LN, Kirschbaum MH, Sela M, Yarden Y . 2000 Adv. Cancer Res. 77: 25–79
Komatsu M, Carraway CAC, Fregien NL, Carraway KL . 1997 J. Biol. Chem. 272: 33245–33254
Komatsu M, Jepson S, Arango ME, Carraway CAC, Carraway KL . 2001 Oncogene 20: 461–470
Komatsu M, Tatum L, Altman NH, Carraway CAC, Carraway KL . 2000 Int. J. Cancer 87: 480–486
Komatsu M, Yee L, Carraway KL . 1999 Cancer Res. 59: 2229–2236
Li P, Arango ME, Perez RE, Reis CA, Bonfante EL, Weed D, Carraway KL . 2001 Tissue Cell 33: 111–118
McNeer RR, Carraway CAC, Fregien NL, Carraway KL . 1998a J. Cell Physiol. 176: 110–119
McNeer RR, Huang D, Fregien NL, Carraway KL . 1998b Biochem. J. 330: 737–744
Olayioye MA, Graus-Porta D, Beerli RR, Rohrer J, Gay B, Hynes NE . 1998 Mol. Cell. Biol. 18: 5042–5051
Pflugfelder SC, Liu Z, Monroy D, Li D-Q, Carvajal ME, Price-Schiavi SA, Idris N, Solomon A, Perez A, Carraway KL . 2000 Invest. Ophthalmol. Vis. Sci. 41: 1316–1326
Price-Schiavi SA, Carraway CAC, Freigien N, Carraway KL . 1998a J. Biol. Chem. 273: 35228–35237
Price-Schiavi SA, Meller D, Jing X, Merritt J, Carvajal ME, Tseng SCG, Carraway KL . 1998b Biochem. J. 335: 457–463
Ricci A, Lanfrancome L, Chiari R, Belardo G, Pertica C, Natali PG, Pelicci PG, Segatto O . 1995 Oncogene 11: 1519–1529
Riese II DJ, Stern DF . 1998 Bioessays 20: 41–48
Rossi EA, McNeer R, Price-Schiavi SA, Komatsu M, Van den Brande JMH, Thompson JF, Carraway CAC, Fregien NL, Carraway KL . 1996 J. Biol. Chem. 271: 33476–33485
Sgambato A, Cittadini A, Faraglia B, Weinstein IB . 2000 J. Cell Physiol. 183: 18–27
Sheng Z, Hull SR, Carraway KL . 1990 J. Biol. Chem. 265: 8505–8510
Sheng Z, Wu K, Carraway KL, Fregien N . 1992 J. Biol. Chem. 267: 16341–16346
Sherblom AP, Carraway KL . 1980 J. Biol. Chem. 255: 12051–12059
Sliwkowski MX, Schaefer G, Akita RW, Lofgren JA, Fitzpatrick VD, Nuijens A, Frendly BM, Cerione RA, Vandlen RL, Carraway III KL . 1994 J. Biol. Chem. 269: 14661–14665
Weed DT, Gomez-Fernandez C, Bonfante E, Lee TD, Pacheco J, Carvajal ME, Goodwin WJ, Carraway KL . 2001 Otolaryngol. Head Neck Surg. 124: 127–141
Wu K, Fregien N, Carraway KL . 1994 J. Biol. Chem. 269: 11950–11955
Yarden Y, Sliwkowski MX . 2001 Nat. Rev. Mol. Cell Biol. 2: 127–137
Acknowledgements
We thank Jin Zhang for help in preparing the manuscript. This research was supported in part by Grant CA74072 from the National Institutes of Health and by the Sylvester Comprehensive Cancer Center of the University of Miami, USA.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jepson, S., Komatsu, M., Haq, B. et al. Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27kip, but does not activate mitogen-activated kinase or protein kinaseB/Akt pathways. Oncogene 21, 7524–7532 (2002). https://doi.org/10.1038/sj.onc.1205970
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205970
Keywords
This article is cited by
-
Roles unveiled for membrane-associated mucins at the ocular surface using a Muc4 knockout mouse model
Scientific Reports (2023)
-
Expression of Mucins in Salivary Gland Mucoepidermoid Carcinoma
Head and Neck Pathology (2021)
-
Exploring the role and diversity of mucins in health and disease with special insight into non-communicable diseases
Glycoconjugate Journal (2015)
-
Specific-detection of clinical samples, systematic functional investigations, and transcriptome analysis reveals that splice variant MUC4/Y contributes to the malignant progression of pancreatic cancer by triggering malignancy-related positive feedback loops signaling
Journal of Translational Medicine (2014)
-
Unraveling the clonal hierarchy of somatic genomic aberrations
Genome Biology (2014)